Xoma reported $-4368000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -97358000 8.25M
Ardelyx ARDX:US USD 12.25M 33.5M
Biomarin Pharmaceutical BMRN:US USD 53K 22.33M
Bluebird Bio BLUE:US USD -85093000 14.32M
Chimerix CMRX:US USD -23789000 35.46M
Emergent Biosolutions EBS:US USD -22600000 15M
Intercept Pharmaceuticals ICPT:US USD -17884000 7.82M
Macrogenics MGNX:US USD 15.21M 37.32M
Novartis NOVN:VX USD 4.5B 193M
Novartis NVS:US USD 4.5B 193M
Pfizer PFE:US USD 6.94B 3.94B
Prothena PRTA:US USD 128K 50.26M
Teva Pharmaceutical Industries TEVA:US USD 1.31B 245M
YTE INCY:US USD 111.58M 23.37M